Precision-oncology diagnostics company applying gene-expression biology to liquid-biopsy sequencing through its ExpressCT fragmentomics platform and biomarker services.
At a glance
- Founded: 2011
- HQ: Durham
- Sector: Biotech
- Stage: Series C
- Total raised: $2.0M
See the full company record.
Founders, funding history and recent signals. Free accounts open immediately.
Listed roles
All Triangle rolesChecking listed roles…